Novo Nordisk has rebounded strongly in 2025, backed by solid financials despite earlier setbacks and competitive risks. See ...

A House bill aiming to increase taxes on tobacco and other related products has been brought before Legislative Hall. Here's what to know.

Crinetics Pharmaceuticals trades at a steep discount while maintaining strong analyst support and a ~$3B valuation. Learn why ...